Business Standard
Ø  US Federal Reserve keeps key rate unchanged
Ø  CAD narrows to $300mn in Q1 on import contraction
Ø  Pricing of 700 MHz spectrum band expensive: Mittal
Ø  India, China may escape worst of global environment: UNCTAD
Ø  Sebi asks NSE to take stock of possible wrongdoing
Ø  Rel Defence in talks to sell vessels to Coast Guard
Ø  IOC, GAIL to take 49% stake in Adani Group’s project
Ø  OECD sees globalisation brake on growth
Ø  Cabinet clears conversion of R&C loan into equity
Ø  Govt irked by Moody’s statement on ratings upgrade
Ø  Sebi to auction Sahara group’s 13 more land parcels
Ø  Cabinet approves closing down Hindustan Diamonds
Ø  ICICI Prudential IPO oversubscribed 10 times
Ø  Nestle seeks SC nod to destroy 550 tonnes of Maggi Noodles

Business Line
Ø  Cabinet approves Rs. 1,250 cr subsidy to BSNL
Ø  Govt extends stock limits on pulses, edible oils by one year
Ø  YES Bank invokes ₹156-crore pledged United Breweries shares
Ø  Seafood industry has a rosy future, says MPEDA chief
Ø  Steel demand likely to grow 5.3% this fiscal
Ø  Essel Propack buys out partner’s stake in JV firm

Mint
Ø  Rupee closes little changed against US dollar
Ø  Adani unveils world’s largest solar plant in Tamil Nadu
Ø  Govt set to fund eastern gas pipeline project
Ø  Suzlon plans to raise $3 billion for Australian wind farms by 2020
Ø  Cabinet approves purchase of 36 Rafale fighter jets: report
Ø  Private equity upbeat on retail commercial space in India

Financial Express
Ø  Markets in wait and watch mode ahead of US Fed outcome
Ø  Marine exports likely to rise 20% to $5.6 billion in 2016-17: Govt
Ø  NTPC gets shareholders’ nod to raise up to Rs15k cr via bonds
Ø  Tata Communications tests UHD broadcast at Singapore F1 race
Ø  SAIL eyes sales of 14.52 MT in FY’17; production of 17.16 MT

Financial Chronicle
Ø  Cabinet approves merging of Rail budget with Union Budget
Ø  Stockholding cap on pulses, edible oils extended
Ø  BOJ rate surprise lifts world stocks ahead of Fed
Ø  Federal Reserve expected to keep rates unchanged
Ø  CIL gears up for double-digit production growth
Ø  Aurobindo Pharma, Cadila recall drugs from US market